Skip Navigation

Department of Health and Human Services

Agency for Healthcare Research Quality

Visit: National Quality Measures Clearinghouse | Health Care Innovations Exchange | AHRQ Home Sign In

National Guideline Clearinghouse

Help| RSS|

Subscribe to weekly e-mail | Site map| Site tutorial Contact us| For web developers

Search

Search Tips Advanced Search About Search

Home

Browse Guidelines

Browse

Expert Commentaries

Guideline Syntheses

Guideline Resources

Annotated Bibliographies

Compare Guidelines

Frequently Asked Questions

Submit Guidelines

About

myNGC

Guidelines by Topic

Disease/Condition > Chemicals and Drugs (7) >

Biological Factors (1)

Narrow:

Blood Coagulation Factors (1)

Search Within Search within: Go

Sort results by: Relevance Publication date

Filter results by:

1-1 of 1

1.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. 2011 Jan. NGC:008278
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group - Independent Expert Panel. View all guidelines by the developer(s)

Compare Selected

1-1 of 1

AHRQ

AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 Telephone: (301) 427-1364